APO Research
Talk to an analyst

APO RESEARCH · REPORT

Andrographolide Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Research

Andrographolide Tablets Industry Research Report 2026

26 December 2025115 pages

Choose your research edition.

Industry ResearchAndrographolide Tablets Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Andrographolide Tablets Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Andrographolide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Andrographolide Tablets Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Andrographolide Tablets Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Andrographolide Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Andrographolide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Andrographolide Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Andrographolide Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Andrographolide Tablets include Guangdong Wannianqing Pharmaceutical Co., Ltd., Sinopharm Group Yibin Pharmaceutical Co., Ltd., Hainan Huipson Pharmaceutical Biotechnology Co., Ltd., Henan Furentang Pharmaceutical Co., Ltd., Hubei Keyi Pharmaceutical Co., Ltd., Jiangxi Qingfeng Pharmaceutical Co., Ltd., Quanzhou Zhongqiao Pharmaceutical Co., Ltd., Wuxi Jiyushanwei Pharmaceutical Co., Ltd. and Chongqing Kerui Pharmaceutical (Group) Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Andrographolide Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Andrographolide Tablets Market by Company

Guangdong Wannianqing Pharmaceutical Co., Ltd.

Sinopharm Group Yibin Pharmaceutical Co., Ltd.

Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.

Henan Furentang Pharmaceutical Co., Ltd.

Hubei Keyi Pharmaceutical Co., Ltd.

Jiangxi Qingfeng Pharmaceutical Co., Ltd.

Quanzhou Zhongqiao Pharmaceutical Co., Ltd.

Wuxi Jiyushanwei Pharmaceutical Co., Ltd.

Chongqing Kerui Pharmaceutical (Group) Co., Ltd.

Andrographolide Tablets Segment by Type

Dispersible Tablets

Conventional Tablets

Andrographolide Tablets Segment by Application

Hospital

Clinic

Other

Andrographolide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Andrographolide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Andrographolide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Andrographolide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Andrographolide Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Andrographolide Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Andrographolide Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Andrographolide Tablets Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Andrographolide Tablets Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Andrographolide Tablets Sales Market Share by Manufacturers (2021-2026) Table 8. Global Andrographolide Tablets Revenue of Manufacturers (2021-2026) Table 9. Global Andrographolide Tablets Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Andrographolide Tablets Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Andrographolide Tablets Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Andrographolide Tablets, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Andrographolide Tablets, Product Type & Application Table 14. Global Andrographolide Tablets Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Andrographolide Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Guangdong Wannianqing Pharmaceutical Co., Ltd. Company Information Table 19. Guangdong Wannianqing Pharmaceutical Co., Ltd. Business Overview Table 20. Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 22. Guangdong Wannianqing Pharmaceutical Co., Ltd. Recent Developments Table 23. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information Table 24. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview Table 25. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 27. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Developments Table 28. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Company Information Table 29. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Business Overview Table 30. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Product Portfolio Table 32. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Recent Developments Table 33. Henan Furentang Pharmaceutical Co., Ltd. Company Information Table 34. Henan Furentang Pharmaceutical Co., Ltd. Business Overview Table 35. Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 37. Henan Furentang Pharmaceutical Co., Ltd. Recent Developments Table 38. Hubei Keyi Pharmaceutical Co., Ltd. Company Information Table 39. Hubei Keyi Pharmaceutical Co., Ltd. Business Overview Table 40. Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 42. Hubei Keyi Pharmaceutical Co., Ltd. Recent Developments Table 43. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Company Information Table 44. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Business Overview Table 45. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 47. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Recent Developments Table 48. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Company Information Table 49. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Business Overview Table 50. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 52. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Recent Developments Table 53. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Company Information Table 54. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Business Overview Table 55. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 57. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Recent Developments Table 58. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information Table 59. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Business Overview Table 60. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Product Portfolio Table 62. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Developments Table 63. Global Andrographolide Tablets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 64. Global Andrographolide Tablets Sales by Region (2021-2026) & (K Units) Table 65. Global Andrographolide Tablets Sales Market Share by Region (2021-2026) Table 66. Global Andrographolide Tablets Sales by Region (2027-2032) & (K Units) Table 67. Global Andrographolide Tablets Sales Market Share by Region (2027-2032) Table 68. Global Andrographolide Tablets Revenue by Region (2021-2026) & (US$ Million) Table 69. Global Andrographolide Tablets Revenue Market Share by Region (2021-2026) Table 70. Global Andrographolide Tablets Revenue by Region (2027-2032) & (US$ Million) Table 71. Global Andrographolide Tablets Revenue Market Share by Region (2027-2032) Table 72. North America Andrographolide Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. North America Andrographolide Tablets Sales by Country (2021-2026) & (K Units) Table 74. North America Andrographolide Tablets Sales by Country (2027-2032) & (K Units) Table 75. North America Andrographolide Tablets Revenue by Country (2021-2026) & (US$ Million) Table 76. North America Andrographolide Tablets Revenue by Country (2027-2032) & (US$ Million) Table 77. Europe Andrographolide Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. Europe Andrographolide Tablets Sales by Country (2021-2026) & (K Units) Table 79. Europe Andrographolide Tablets Sales by Country (2027-2032) & (K Units) Table 80. Europe Andrographolide Tablets Revenue by Country (2021-2026) & (US$ Million) Table 81. Europe Andrographolide Tablets Revenue by Country (2027-2032) & (US$ Million) Table 82. Asia Pacific Andrographolide Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Asia Pacific Andrographolide Tablets Sales by Country (2021-2026) & (K Units) Table 84. Asia Pacific Andrographolide Tablets Sales by Country (2027-2032) & (K Units) Table 85. Asia Pacific Andrographolide Tablets Revenue by Country (2021-2026) & (US$ Million) Table 86. Asia Pacific Andrographolide Tablets Revenue by Country (2027-2032) & (US$ Million) Table 87. South America Andrographolide Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. South America Andrographolide Tablets Sales by Country (2021-2026) & (K Units) Table 89. South America Andrographolide Tablets Sales by Country (2027-2032) & (K Units) Table 90. South America Andrographolide Tablets Revenue by Country (2021-2026) & (US$ Million) Table 91. South America Andrographolide Tablets Revenue by Country (2027-2032) & (US$ Million) Table 92. Middle East and Africa Andrographolide Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Middle East and Africa Andrographolide Tablets Sales by Country (2021-2026) & (K Units) Table 94. Middle East and Africa Andrographolide Tablets Sales by Country (2027-2032) & (K Units) Table 95. Middle East and Africa Andrographolide Tablets Revenue by Country (2021-2026) & (US$ Million) Table 96. Middle East and Africa Andrographolide Tablets Revenue by Country (2027-2032) & (US$ Million) Table 97. Global Andrographolide Tablets Sales by Type (2021-2026) & (K Units) Table 98. Global Andrographolide Tablets Sales by Type (2027-2032) & (K Units) Table 99. Global Andrographolide Tablets Sales Market Share by Type (2021-2026) Table 100. Global Andrographolide Tablets Sales Market Share by Type (2027-2032) Table 101. Global Andrographolide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 102. Global Andrographolide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 103. Global Andrographolide Tablets Revenue Market Share by Type (2021-2026) Table 104. Global Andrographolide Tablets Revenue Market Share by Type (2027-2032) Table 105. Global Andrographolide Tablets Price by Type (2021-2026) & (US$/Unit) Table 106. Global Andrographolide Tablets Price by Type (2027-2032) & (US$/Unit) Table 107. Global Andrographolide Tablets Sales by Application (2021-2026) & (K Units) Table 108. Global Andrographolide Tablets Sales by Application (2027-2032) & (K Units) Table 109. Global Andrographolide Tablets Sales Market Share by Application (2021-2026) Table 110. Global Andrographolide Tablets Sales Market Share by Application (2027-2032) Table 111. Global Andrographolide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 112. Global Andrographolide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 113. Global Andrographolide Tablets Revenue Market Share by Application (2021-2026) Table 114. Global Andrographolide Tablets Revenue Market Share by Application (2027-2032) Table 115. Global Andrographolide Tablets Price by Application (2021-2026) & (US$/Unit) Table 116. Global Andrographolide Tablets Price by Application (2027-2032) & (US$/Unit) Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Andrographolide Tablets Distributors List Table 120. Andrographolide Tablets Customers List Table 121. Andrographolide Tablets Industry Trends Table 122. Andrographolide Tablets Industry Drivers Table 123. Andrographolide Tablets Industry Restraints Table 124. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Andrographolide Tablets Product Image Figure 5. Global Andrographolide Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Andrographolide Tablets Market Size (2021-2032) & (US$ Million) Figure 7. Global Andrographolide Tablets Sales (2021-2032) & (K Units) Figure 8. Global Andrographolide Tablets Average Price (US$/Unit) & (2021-2032) Figure 9. Dispersible Tablets Product Image Figure 10. Conventional Tablets Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Other Product Image Figure 14. Global Andrographolide Tablets Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Andrographolide Tablets, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Andrographolide Tablets Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Andrographolide Tablets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Andrographolide Tablets Sales by Region in 2025 Figure 20. Global Andrographolide Tablets Revenue by Region in 2025 Figure 21. North America Andrographolide Tablets Market Size by Country in 2025 Figure 22. North America Andrographolide Tablets Sales Market Share by Country (2021-2032) Figure 23. North America Andrographolide Tablets Revenue Market Share by Country (2021-2032) Figure 24. United States Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Andrographolide Tablets Market Size by Country in 2025 Figure 28. Europe Andrographolide Tablets Sales Market Share by Country (2021-2032) Figure 29. Europe Andrographolide Tablets Revenue Market Share by Country (2021-2032) Figure 30. Germany Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Andrographolide Tablets Market Size by Country in 2025 Figure 41. Asia Pacific Andrographolide Tablets Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Andrographolide Tablets Revenue Market Share by Country (2021-2032) Figure 43. China Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Andrographolide Tablets Market Size by Country in 2025 Figure 52. South America Andrographolide Tablets Sales Market Share by Country (2021-2032) Figure 53. South America Andrographolide Tablets Revenue Market Share by Country (2021-2032) Figure 54. Brazil Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Andrographolide Tablets Market Size by Country in 2025 Figure 58. Middle East and Africa Andrographolide Tablets Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Andrographolide Tablets Revenue Market Share by Country (2021-2032) Figure 60. Egypt Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Andrographolide Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Andrographolide Tablets Sales Market Share by Type (2021-2032) Figure 66. Global Andrographolide Tablets Revenue Market Share by Type (2021-2032) Figure 67. Global Andrographolide Tablets Price (US$/Unit) by Type (2021-2032) Figure 68. Global Andrographolide Tablets Sales Market Share by Application (2021-2032) Figure 69. Global Andrographolide Tablets Revenue Market Share by Application (2021-2032) Figure 70. Global Andrographolide Tablets Price (US$/Unit) by Application (2021-2032) Figure 71. Andrographolide Tablets Value Chain Figure 72. Andrographolide Tablets Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Andrographolide Tablets Industry Opportunities and Challenges

Scope & coverage.

Types
  • Dispersible Tablets
  • Conventional Tablets
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Guangdong Wannianqing Pharmaceutical Co., Ltd.
  • Sinopharm Group Yibin Pharmaceutical Co., Ltd.
  • Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.
  • Henan Furentang Pharmaceutical Co., Ltd.
  • Hubei Keyi Pharmaceutical Co., Ltd.
  • Jiangxi Qingfeng Pharmaceutical Co., Ltd.
  • Quanzhou Zhongqiao Pharmaceutical Co., Ltd.
  • Wuxi Jiyushanwei Pharmaceutical Co., Ltd.
  • Chongqing Kerui Pharmaceutical (Group) Co., Ltd.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Andrographolide Tablets Market Size (2021-2032)
  4. 2.2.2 Global Andrographolide Tablets Sales (2021-2032)
  5. 2.2.3 Global Andrographolide Tablets Market Average Price (2021-2032)
  6. 2.3 Andrographolide Tablets by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Dispersible Tablets
  9. 2.3.3 Conventional Tablets
  10. 2.4 Andrographolide Tablets by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Andrographolide Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Andrographolide Tablets Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Andrographolide Tablets Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Andrographolide Tablets Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Andrographolide Tablets Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Andrographolide Tablets, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Andrographolide Tablets, Product Type & Application
  8. 3.8 Global Manufacturers of Andrographolide Tablets, Established Date
  9. 3.9 Global Andrographolide Tablets Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Guangdong Wannianqing Pharmaceutical Co., Ltd.
  2. 4.1.1 Guangdong Wannianqing Pharmaceutical Co., Ltd. Company Information
  3. 4.1.2 Guangdong Wannianqing Pharmaceutical Co., Ltd. Business Overview
  4. 4.1.3 Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  6. 4.1.5 Guangdong Wannianqing Pharmaceutical Co., Ltd. Recent Developments
  7. 4.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd.
  8. 4.2.1 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information
  9. 4.2.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview
  10. 4.2.3 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  12. 4.2.5 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Developments
  13. 4.3 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.
  14. 4.3.1 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Company Information
  15. 4.3.2 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Business Overview
  16. 4.3.3 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Product Portfolio
  18. 4.3.5 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Recent Developments
  19. 4.4 Henan Furentang Pharmaceutical Co., Ltd.
  20. 4.4.1 Henan Furentang Pharmaceutical Co., Ltd. Company Information
  21. 4.4.2 Henan Furentang Pharmaceutical Co., Ltd. Business Overview
  22. 4.4.3 Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  24. 4.4.5 Henan Furentang Pharmaceutical Co., Ltd. Recent Developments
  25. 4.5 Hubei Keyi Pharmaceutical Co., Ltd.
  26. 4.5.1 Hubei Keyi Pharmaceutical Co., Ltd. Company Information
  27. 4.5.2 Hubei Keyi Pharmaceutical Co., Ltd. Business Overview
  28. 4.5.3 Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  30. 4.5.5 Hubei Keyi Pharmaceutical Co., Ltd. Recent Developments
  31. 4.6 Jiangxi Qingfeng Pharmaceutical Co., Ltd.
  32. 4.6.1 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Company Information
  33. 4.6.2 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Business Overview
  34. 4.6.3 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  36. 4.6.5 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Recent Developments
  37. 4.7 Quanzhou Zhongqiao Pharmaceutical Co., Ltd.
  38. 4.7.1 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Company Information
  39. 4.7.2 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Business Overview
  40. 4.7.3 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  42. 4.7.5 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Recent Developments
  43. 4.8 Wuxi Jiyushanwei Pharmaceutical Co., Ltd.
  44. 4.8.1 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Company Information
  45. 4.8.2 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Business Overview
  46. 4.8.3 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  48. 4.8.5 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Recent Developments
  49. 4.9 Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
  50. 4.9.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information
  51. 4.9.2 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Business Overview
  52. 4.9.3 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Product Portfolio
  54. 4.9.5 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Developments
5 Global Andrographolide Tablets Market Scenario by Region
  1. 5.1 Global Andrographolide Tablets Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Andrographolide Tablets Sales by Region: 2021-2032
  3. 5.2.1 Global Andrographolide Tablets Sales by Region: 2021-2026
  4. 5.2.2 Global Andrographolide Tablets Sales by Region: 2027-2032
  5. 5.3 Global Andrographolide Tablets Revenue by Region: 2021-2032
  6. 5.3.1 Global Andrographolide Tablets Revenue by Region: 2021-2026
  7. 5.3.2 Global Andrographolide Tablets Revenue by Region: 2027-2032
  8. 5.4 North America Andrographolide Tablets Market Facts & Figures by Country
  9. 5.4.1 North America Andrographolide Tablets Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Andrographolide Tablets Sales by Country (2021-2032)
  11. 5.4.3 North America Andrographolide Tablets Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Andrographolide Tablets Market Facts & Figures by Country
  16. 5.5.1 Europe Andrographolide Tablets Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Andrographolide Tablets Sales by Country (2021-2032)
  18. 5.5.3 Europe Andrographolide Tablets Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Andrographolide Tablets Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Andrographolide Tablets Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Andrographolide Tablets Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Andrographolide Tablets Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Andrographolide Tablets Market Facts & Figures by Country
  41. 5.7.1 South America Andrographolide Tablets Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Andrographolide Tablets Sales by Country (2021-2032)
  43. 5.7.3 South America Andrographolide Tablets Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Andrographolide Tablets Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Andrographolide Tablets Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Andrographolide Tablets Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Andrographolide Tablets Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Andrographolide Tablets Sales by Type (2021-2032)
  2. 6.1.1 Global Andrographolide Tablets Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Andrographolide Tablets Sales Market Share by Type (2021-2032)
  4. 6.2 Global Andrographolide Tablets Revenue by Type (2021-2032)
  5. 6.2.1 Global Andrographolide Tablets Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Andrographolide Tablets Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Andrographolide Tablets Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Andrographolide Tablets Sales by Application (2021-2032)
  2. 7.1.1 Global Andrographolide Tablets Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Andrographolide Tablets Sales Market Share by Application (2021-2032)
  4. 7.2 Global Andrographolide Tablets Revenue by Application (2021-2032)
  5. 7.2.1 Global Andrographolide Tablets Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Andrographolide Tablets Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Andrographolide Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Andrographolide Tablets Value Chain Analysis
  2. 8.1.1 Andrographolide Tablets Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Andrographolide Tablets Production Mode & Process
  5. 8.2 Andrographolide Tablets Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Andrographolide Tablets Distributors
  8. 8.2.3 Andrographolide Tablets Customers
9 Global Andrographolide Tablets Analyzing Market Dynamics
  1. 9.1 Andrographolide Tablets Industry Trends
  2. 9.2 Andrographolide Tablets Industry Drivers
  3. 9.3 Andrographolide Tablets Industry Opportunities and Challenges
  4. 9.4 Andrographolide Tablets Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst